| Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms MA Rossi, HB Tanowitz, LM Malvestio, MR Celes, EC Campos, V Blefari, ... PLoS neglected tropical diseases 4 (8), e674, 2010 | 157 | 2010 |
| Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and functional changes in severe sepsis MRN Celes, LM Malvestio, SO Suadicani, CM Prado, MJ Figueiredo, ... PLoS One 8 (7), e68809, 2013 | 68 | 2013 |
| Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy EC Campos, JL O'Connell, LM Malvestio, MMD Romano, SG Ramos, ... European journal of pharmacology 670 (2-3), 541-553, 2011 | 52 | 2011 |
| Increased sarcolemmal permeability as an early event in experimental septic cardiomyopathy: a potential role for oxidative damage to lipids and proteins MRN Celes, D Torres-Dueñas, CM Prado, EC Campos, JE Moreira, ... Shock 33 (3), 322-331, 2010 | 43 | 2010 |
| Disruption of sarcolemmal dystrophin and β-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis MR Celes, D Torres-Duenas, L Malvestio, V Blefari, E Campos, C Prado, ... Critical Care 14, 1-1, 2010 | 42 | 2010 |
| Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury EC Campos, MMD Romano, CM Prado, MA Rossi International journal of experimental pathology 89 (5), 367-381, 2008 | 34 | 2008 |
| Activation of both the calpain and ubiquitin-proteasome systems contributes to septic cardiomyopathy through dystrophin loss/disruption and mTOR inhibition ACS Freitas, MJ Figueiredo, EC Campos, DF Soave, SG Ramos, ... PLoS One 11 (11), e0166839, 2016 | 23 | 2016 |
| Doxorubicin-induced cardiotoxicity and cardioprotective agents: classic and new players in the game F dos Santos Arruda, FD Tomé, MP Miguel, LB de Menezes, PRA Nagib, ... Current pharmaceutical design 25 (2), 109-118, 2019 | 21 | 2019 |
| Early detection of doxorubicin myocardial injury by ultrasonic tissue characterization in an experimental animal model MMD Romano, A Pazin-Filho, JL O’Connel, MV Simões, A Schmidt, ... Cardiovascular ultrasound 10, 1-8, 2012 | 18 | 2012 |
| Early dystrophin disruption in the pathogenesis of experimental chronic Chagas cardiomyopathy CM Prado, MRN Celes, LM Malvestio, EC Campos, JS Silva, LA Jelicks, ... Microbes and infection 14 (1), 59-68, 2012 | 17 | 2012 |
| Increased atrial β-adrenergic receptors and GRK-2 gene expression can play a fundamental role in heart failure after repair of congenital heart disease with cardiopulmonary bypass MS Oliveira, F Carmona, WVA Vicente, PH Manso, KM Mata, MR Celes, ... Pediatric cardiology 38, 734-745, 2017 | 8 | 2017 |
| Physical training improves cardiac structure and function of rats after doxorubicin-induced cardiomyopathy FR Souza, ÉC Campos, LTP Lopes, CM Rodrigues, DLN Gonçalves, ... International Journal of Cardiovascular Sciences 35, 718-726, 2022 | 4 | 2022 |
| Effects of physical exercise and thyroid hormone on myosin heavy chain expression in doxorubicin‐induced cardiotoxicity in rats EC Campos, FR Souza, ACS Freitas, SG Ramos, ES Resende The FASEB Journal 30, 1178.3-1178.3, 2016 | 1 | 2016 |
| Calcium channel blocking drugs ameliorates the experimental septic cardiomyopathy induced by cecal ligation and puncture in mice MRN Celes, CM Prado, EC Campos, LM Malvestio, P Ferezin, ... The FASEB Journal 26, 835.15-835.15, 2012 | 1 | 2012 |
| Loss of sarcolemmal dystrophin and dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis MRN Celes, D Torres-Dueñas, DB Duarte, EC Campos, CM Prado, ... Critical Care 13, 1-2, 2009 | 1 | 2009 |
| Efficacy of Different Cumulative Doses of Doxorubicin in the Induction of a Dilated Cardiomyopathy Model in Rats DM Tanaka, JL O’Connell, CG Fabricio, MMD Romano, EC Campos, ... ABC Heart Fail Cardiomyop 2 (3), 242-249, 2022 | | 2022 |
| Activation of calpain-1 and ubiquitin-proteasome system leads to dystrophin loss through inhibition of mTOR during septic cardiomyopathy MR Celes, AC Freitas, MJ Figueiredo, EC Campos, DF Soave, SG Ramos VIRCHOWS ARCHIV 467, S111-S111, 2015 | | 2015 |
| Autophagy activation in the cardiovascular system after two-hit sepsis model MR Celes, MJ Figueiredo, AC Freitas, DC Nascimento, EC Campos, ... VIRCHOWS ARCHIV 467 (SUPPL 1), S113-S113, 2015 | | 2015 |
| Calpain‐1 inhibitor prevent loss of dystrophin in experimental septic cardiomyopathy induced by cecal ligation and puncture (CLP) ACS Freitas, MJ Figueiredo, P Ferezin, EC Campos, MA Rossi, MR Celes The FASEB Journal 27, lb479-lb479, 2013 | | 2013 |
| The possible role of serum from septic mice in dystrophin proteolysis in cultured newborn mice cardiomyocytes LMM Malvestio, CM Prado, MRN Celes, EC Campos, PM Ferezin, ... The FASEB Journal 27, 1085.2-1085.2, 2013 | | 2013 |
Marcos RossiProfessor de Patologia, Universidade de São Paulo在 fmrp.usp.br 的电子邮件经过验证
